Demo corpus. Scores are computed on a select set of biomedical paper/datasets and may be inaccurate for papers outside this corpus — DataRank relies on network effects that improve with scale. We aim to expand this into a fully open resource pending additional funding.

Genomic medicine on the frontier of precision medicine

Journal of Diabetes & Metabolic Disorders(2021)10.1007/s40200-021-00880-6Source: DataRank Database

Genomic medicine on the frontier of precision medicine is a research paper published in Journal of Diabetes & Metabolic Disorders (2021). On theSindex it has a DataRank of 0.766. It has been cited 18 times, with 15 citing works in its 1-hop citation network.

N/A

0.766DataRank · unranked

0.766

18 citations · base score 2.9

Cite:

datarank_citation_only_1hop_v6· scope data_onlyMethodology

›Data sources & pipeline

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Pending

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

DataRank Breakdown

Base Score 58%Citation Network 42%

Base Score Contribution

0.442

From this paper's citation signal

Citation Network Contribution

0.324

From 9 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by citation count — the same ordering the engine uses when summing log1p(C_q) over citers.

Initial sequencing and analysis of the human genome
Nature200124,542 citationsDataRank 17.1Top 10%
A haplotype map of the human genome
Nature20055,917 citationsDataRank 29.2Top 1%
Finishing the euchromatic sequence of the human genome
Nature20044,903 citationsDataRank 20.0Top 5%
Translational precision medicine: an industry perspective
Journal of Translational Medicine2021129 citationsDataRank 3.5
Genomic Medicine, Precision Medicine, Personalized Medicine: What’s in a Name?
Clinical Pharmacology & Therapeutics201374 citationsDataRank 3.8

Why this DataRank?

DataRank blends this paper's own citation count with the influence of the papers that cite it. Here, roughly 58% comes from its base citations and 42% from the citation network (9 citing papers contributed measurable signal).

Base score B(p): log1p(citation_count) — grows sub-linearly, so a paper with 1,000 citations is not 10× a paper with 100.
Network N(p): Σ over citers of log1p(C_q) ÷ max(outdegree_q, 1). Being cited by a highly-cited paper with few references counts most.
Damping factor d = 0.85: DataRank = (1−d)·B(p) + d·N(p) — the two cards above are each already multiplied by their share.
Self-citations excluded: Citers sharing any OpenAlex author ID with this paper are filtered out before the network sum.

Citers are pulled from OpenAlex sorted by cited_by_count:descand capped per paper, so when the cap binds we keep the highest-signal references and the score is reproducible across reruns.

Read the full methodology →

Click a node to highlight its connections. Use scroll to zoom. Drag to pan.

Node colors:CenterData PaperData + Open AccessNon-dataSelected & links| Node size = percentile rank